Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Investment analysts at Dougherty & Co cut their Q3 2017 earnings per share (EPS) estimates for Allscripts Healthcare Solutions in a research note issued on Thursday. Dougherty & Co analyst G. Mannheimer now forecasts that the software maker will post earnings per share of $0.12 for the quarter, down from their prior forecast of $0.13. Dougherty & Co also issued estimates for Allscripts Healthcare Solutions’ FY2017 earnings at $0.47 EPS and FY2018 earnings at $0.57 EPS.

A number of other brokerages also recently commented on MDRX. Morgan Stanley increased their price objective on Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the company an “underweight” rating in a research report on Monday, August 7th. Maxim Group reiterated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Piper Jaffray Companies reiterated a “hold” rating and set a $14.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. Citigroup Inc. increased their price objective on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Monday, August 7th. Finally, Zacks Investment Research upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $14.59.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/21/research-analysts-issue-forecasts-for-allscripts-healthcare-solutions-inc-s-q3-2017-earnings-mdrx.html.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 12.85 on Monday. The firm’s 50-day moving average price is $12.51 and its 200 day moving average price is $12.21. Allscripts Healthcare Solutions has a 52-week low of $9.80 and a 52-week high of $13.70. The stock’s market cap is $2.32 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.04. The company had revenue of $426.10 million for the quarter, compared to analysts’ expectations of $424.94 million. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business’s quarterly revenue was up 10.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.14 EPS.

A number of hedge funds have recently made changes to their positions in MDRX. World Asset Management Inc increased its position in Allscripts Healthcare Solutions by 0.7% in the second quarter. World Asset Management Inc now owns 11,419 shares of the software maker’s stock worth $146,000 after buying an additional 81 shares during the period. Advantus Capital Management Inc increased its position in Allscripts Healthcare Solutions by 0.5% in the first quarter. Advantus Capital Management Inc now owns 23,112 shares of the software maker’s stock worth $293,000 after buying an additional 109 shares during the period. Atlantic Trust Group LLC increased its position in Allscripts Healthcare Solutions by 0.3% in the second quarter. Atlantic Trust Group LLC now owns 32,900 shares of the software maker’s stock worth $420,000 after buying an additional 110 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Allscripts Healthcare Solutions by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,484 shares of the software maker’s stock worth $338,000 after buying an additional 115 shares during the period. Finally, Capstone Asset Management Co. increased its position in Allscripts Healthcare Solutions by 1.4% in the first quarter. Capstone Asset Management Co. now owns 16,977 shares of the software maker’s stock worth $215,000 after buying an additional 230 shares during the period.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.